Total Payments
$111,876
2024 Payments
$20,891
Companies
25
Transactions
490
Medicare Patients
168
Medicare Billing
$10,766
Payment Breakdown by Category
Other$92,968 (83.1%)
Travel$11,466 (10.2%)
Food & Beverage$7,432 (6.6%)
Education$10.74 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $90,693 | 64 | 81.1% |
| Travel and Lodging | $11,466 | 46 | 10.2% |
| Food and Beverage | $7,432 | 376 | 6.6% |
| Honoraria | $2,275 | 1 | 2.0% |
| Education | $10.74 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | $66,054 | 149 | $0 (2024) |
| IRONSHORE PHARMACEUTICALS INC. | $36,344 | 87 | $0 (2024) |
| Allergan, Inc. | $5,952 | 57 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $554.26 | 17 | $0 (2024) |
| Tris Pharma Inc | $424.63 | 30 | $0 (2021) |
| Shire North American Group Inc | $352.63 | 10 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $350.03 | 22 | $0 (2021) |
| Lundbeck LLC | $288.41 | 18 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $273.80 | 17 | $0 (2020) |
| Neurocrine Biosciences, Inc. | $236.14 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20,891 | 71 | Supernus Pharmaceuticals, Inc. ($20,690) |
| 2023 | $14,573 | 50 | Supernus Pharmaceuticals, Inc. ($11,195) |
| 2022 | $17,923 | 47 | Supernus Pharmaceuticals, Inc. ($11,506) |
| 2021 | $25,312 | 60 | Supernus Pharmaceuticals, Inc. ($22,663) |
| 2020 | $15,796 | 72 | Ironshore Pharmaceuticals Inc. ($9,602) |
| 2019 | $15,846 | 90 | Ironshore Pharmaceuticals Inc. ($14,833) |
| 2018 | $634.36 | 43 | Otsuka America Pharmaceutical, Inc. ($166.11) |
| 2017 | $901.11 | 57 | Shire North American Group Inc ($300.66) |
All Payment Transactions
490 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $10.10 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $9.86 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $9.46 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $10.18 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $8.91 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 09/14/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 08/31/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 08/31/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 08/30/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $23.12 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 08/29/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $7.97 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 08/13/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $10.02 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 08/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $8.54 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 08/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $7.76 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 07/31/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,750.00 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 07/31/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,750.00 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 07/31/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 07/31/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Travel and Lodging | In-kind items and services | $294.56 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 07/31/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $62.57 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 07/31/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Travel and Lodging | In-kind items and services | $43.94 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 07/31/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Travel and Lodging | In-kind items and services | $43.94 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 07/31/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Travel and Lodging | In-kind items and services | $43.93 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 07/31/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 07/31/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 07/31/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Travel and Lodging | In-kind items and services | $5.00 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 07/30/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,750.00 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 40 | 44 | $6,050 | $2,051 |
| 2021 | 2 | 98 | 117 | $22,425 | $6,833 |
| 2020 | 1 | 30 | 33 | $4,950 | $1,883 |
Total Patients
168
Total Services
194
Medicare Billing
$10,766
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 22 | $3,300 | $1,335 | 40.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 22 | $2,750 | $715.94 | 26.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 34 | 46 | $12,300 | $2,563 | 20.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 25 | 32 | $5,250 | $2,270 | 43.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 24 | 24 | $3,000 | $1,238 | 41.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 15 | $1,875 | $762.34 | 40.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 30 | 33 | $4,950 | $1,883 | 38.0% |
About Dr. Steven Croley, MD
Dr. Steven Croley, MD is a Psychiatry healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1265559272.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Croley, MD has received a total of $111,876 in payments from pharmaceutical and medical device companies, with $20,891 received in 2024. These payments were reported across 490 transactions from 25 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($90,693).
As a Medicare-enrolled provider, Croley has provided services to 168 Medicare beneficiaries, totaling 194 services with total Medicare billing of $10,766. Data is available for 3 years (2020–2022), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Child & Adolescent Psychiatry
- Location Lexington, KY
- Active Since 03/23/2007
- Last Updated 03/25/2014
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1265559272
Products in Payments
- QELBREE (Drug) $42,916
- JORNAY PM (Drug) $21,510
- Qelbree (Drug) $20,690
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $14,833
- VRAYLAR (Drug) $5,976
- LATUDA (Drug) $338.78
- SPRAVATO (Drug) $335.44
- REXULTI (Drug) $330.70
- Dyanavel XR (Drug) $315.96
- INGREZZA (Drug) $236.14
- Azstarys (Drug) $235.82
- INVEGA SUSTENNA (Drug) $218.82
- Evekeo (Drug) $134.57
- TRINTELLIX (Drug) $121.39
- ABILIFY MAINTENA (Drug) $110.12
- Quillivant XR (Drug) $108.67
- WELLBUTRIN XL (Drug) $100.02
- NEUROSTAR TMS THERAPY (Device) $94.90
- VYVANSE (Drug) $80.23
- Aptensio XR (Drug) $79.78
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Lexington
Mark Wright, M.d, M.D
Psychiatry — Payments: $619,046
Psychiatry $619,046
Syed Rizvi, M.d, M.D
Psychiatry — Payments: $17,719
Psychiatry $17,719
Dr. Paolo Cassano, Md, Phd, MD, PHD
Psychiatry — Payments: $12,649
Psychiatry $12,649
Kathleen Lundvall, Md, MD
Psychiatry — Payments: $9,100
Psychiatry $9,100
Dr. Getulio Tovar, M.d, M.D
Psychiatry — Payments: $9,055
Psychiatry $9,055
Mr. Saeed Hamid, M.d, M.D
Psychiatry — Payments: $8,148
Psychiatry $8,148